251 of Total
Incyte to Present at Upcoming Investor Conferences
252 of Total
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatm
253 of Total
Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Derm
254 of Total
Incyte Events
255 of Total
Incyte News Releases
256 of Total
Incyte SEC Filings
